M33.13 coverage policies: Medicare and commercial payers

55 active Medicare policies list M33.13, and 1 commercial payer policy lists it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.

Get free alerts for M33.13

Free account. Policy pages stay open to everyone.

Medicare policies listing M33.13

LCD · NORIDIAN-JE-L39116

Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

JE · Effective Nov 12, 2023

LCD · NORIDIAN-JF-L39116

Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

JF · Effective Nov 12, 2023

LCD · PALMETTO-JJ-L39128

Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

JJ · Effective Apr 30, 2023

LCD · PALMETTO-JM-L39128

Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

JM · Effective Apr 30, 2023

LCD · WPS-J5-L37205

Chemotherapy Drugs and their Adjuncts

J5 · Effective Sep 16, 2017

LCD · WPS-J8-L37205

Chemotherapy Drugs and their Adjuncts

J8 · Effective Sep 16, 2017

LCD · FIRST_COAST-L34007

Immune Globulin

J9 · Effective Oct 1, 2015

LCD · NOVITAS-JH-L35093

Immune Globulin

JH · Effective Oct 1, 2015

LCD · NOVITAS-JL-L35093

Immune Globulin

JL · Effective Oct 1, 2015

Commercial payer policies listing M33.13

1 policy from 1 payer

Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.

Anthem

Anthem policies listing M33.13, with the code’s status in each
Policy	Effective	Status of M33.13
Prostate Specific Antigen TestingClinical Guideline · ANTHEM-CG-LAB-28	Apr 15, 2026	Covered